Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scholar Rock Holding Corp

32.77
+1.103.47%
Post-market: 32.47-0.3000-0.92%17:06 EDT
Volume:1.72M
Turnover:55.59M
Market Cap:3.11B
PE:-12.48
High:33.01
Open:31.57
Low:31.03
Close:31.67
Loading ...

Scholar Rock Holding Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Scholar Rock's 2024 Loss Widens

MT Newswires Live
·
27 Feb

Scholar Rock Holding Q4 EPS $(0.61) Misses $(0.60) Estimate

Benzinga
·
27 Feb

Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress

Business Wire
·
27 Feb

Scholar Rock to Participate in Upcoming Investor Conferences

Business Wire
·
26 Feb

Scholar Rock Holding Corp expected to post a loss of 60 cents a share - Earnings Preview

Reuters
·
25 Feb

Is Scholar Rock Holding (SRRK) One of the Oversold Biotech Stocks to Buy Now?

Insider Monkey
·
25 Feb

Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Business Wire
·
21 Feb

FOCUS-Next generation weight loss drugs aim to save muscle

Reuters
·
19 Feb

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
15 Feb

Scholar Rock to Host Conference Call to Discuss Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Update on February 27, 2025

THOMSON REUTERS
·
10 Feb

Scholar Rock Files US FDA Application for Apitegromab in Spinal Muscular Atrophy

MT Newswires Live
·
29 Jan

Scholar Rock Names Lisa Wyman as Chief Technical, Quality Officer, COO Role to Be Eliminated

MT Newswires Live
·
29 Jan

Scholar Rock submits apitegromab BLA to FDA

TIPRANKS
·
29 Jan

BRIEF-Scholar Rock Holding To Submit MAA To EMA In 1Q 2025

Reuters
·
29 Jan

Scholar Rock Holding Corp - to Submit Maa to Ema in 1Q 2025

THOMSON REUTERS
·
29 Jan

Scholar Rock Submits Biologics License Application (Bla) to the U.S. FDA for Apitegromab as a Treatment for Patients With Spinal Muscular Atrophy (Sma)

THOMSON REUTERS
·
29 Jan

Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership Transition

THOMSON REUTERS
·
29 Jan

Scholar Rock Holding Corp : JP Morgan Raises Target Price to $52 From $33

THOMSON REUTERS
·
22 Jan

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
18 Jan